CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-05 | Patil Neena M EVP and Chief Legal Officer | Shares withheld for taxes | −1,321 | $153.72 | $203K | 30,279 |
| 2022-08-04 | Pearce Samantha SVP, Head of Europe & Internat | Option exercise | +531 | $109.45 | $58K | 11,840 |
| 2022-08-04 | Pearce Samantha SVP, Head of Europe & Internat | Sale | −531 | $155.00 | $82K | 11,309 |
| 2022-08-04 | Pearce Samantha SVP, Head of Europe & Internat | Option exercise · Non-Qualified Stock Option (right to buy) | −531 | 10,094 | ||
| 2022-08-01 | COZADD BRUCE C Chairman & CEO | Option exercise | +9,632 | $46.83 | $451K | 361,544 |
| 2022-08-01 | COZADD BRUCE C Chairman & CEO | Option exercise | +68 | $59.13 | $4K | 361,612 |
| 2022-08-01 | COZADD BRUCE C Chairman & CEO | Sale | −2,600 | $153.48 | $399K | 359,012 |
| 2022-08-01 | COZADD BRUCE C Chairman & CEO | Sale | −2,601 | $154.50 | $402K | 356,411 |
| 2022-08-01 | COZADD BRUCE C Chairman & CEO | Sale | −1,100 | $155.27 | $171K | 355,311 |
| 2022-08-01 | COZADD BRUCE C Chairman & CEO | Sale | −1,000 | $154.94 | $155K | 354,311 |
| 2022-08-01 | COZADD BRUCE C Chairman & CEO | Option exercise · Non-Qualified Stock Option (right to buy) | −9,632 | 0 | ||
| 2022-08-01 | COZADD BRUCE C Chairman & CEO | Option exercise · Non-Qualified Stock Option (right to buy) | −68 | 72,605 | ||
| 2022-07-12 | Pearce Samantha SVP, Head of Europe & Internat | Option exercise | +532 | $109.45 | $58K | 11,841 |
| 2022-07-12 | Pearce Samantha SVP, Head of Europe & Internat | Sale | −532 | $155.00 | $82K | 11,309 |
| 2022-07-12 | Pearce Samantha SVP, Head of Europe & Internat | Option exercise · Non-Qualified Stock Option (right to buy) | −532 | 10,625 | ||
| 2022-07-05 | Tovey Christopher J. EVP, COO & Managing Director E | Option exercise | +4,032 | $0.02 | $81 | 19,872 |
| 2022-07-05 | Tovey Christopher J. EVP, COO & Managing Director E | Sale | −4,032 | $160.00 | $645K | 15,840 |
| 2022-07-05 | Tovey Christopher J. EVP, COO & Managing Director E | Sale | −1,177 | $160.00 | $188K | 14,663 |
| 2022-07-05 | Tovey Christopher J. EVP, COO & Managing Director E | Option exercise · Non-Qualified Stock Option (right to buy) | −4,032 | 4,031 | ||
| 2022-07-05 | COZADD BRUCE C Chairman & CEO | Option exercise | +9,700 | $46.83 | $454K | 360,687 |
Page 25 of 31 · 614 trades